15
Views
2
CrossRef citations to date
0
Altmetric
Research Article

Contributions of Neuropathology to Understanding Schizophrenia in Late Life

Pages 69-76 | Published online: 03 Jul 2009

REFERENCES

  • Kraepelin E. Dementia praecox and paraphrenia. Edin- burgh: Livingstone, 1919.
  • Bleuler E. Textbook of psychiatry. New York: Macmillan, 1924.
  • Bleuler M. A 23-year longitudinal study of 208 schizophren- ics and impressions in regard to the nature of schizophrenia. In: Rosenthal D, Kety SS, eds. The transmission of schizo- phrenia. New York: Pergamon Press, 1968:3–12.
  • Carpenter WT, Kirkpatrick B. The heterogeneity of the long- term course of schizophrenia. Schizophr Bull 1988;14:645–52.
  • Ciompi L. Catamnestic long-term study on the course of life and aging of schizophrenics. Schizophr Bull 1980;6:606–18.
  • Lindstrom LH. Clinical and biological markers for outcome in schizophrenia: a review of a longitudinal follow-up study in Uppsala schizophrenia research project. Neuropsycho- pharmacology 1996;14(3,suppl):23-6S.
  • Winokur G, Pfohl B, Tsuang M. A 40-year follow-up of hebe- phrenic-catatonic schizophrenia. In: Miller N, Cohen G, eds. Schizophrenia and aging. New York: Guilford Press, 1987: 52–60.
  • Davidson M, Harvey PD, Powchik P, Parella M, White L, Knobler HY, et al. Severity of symptoms in chronically insti- tutionalized geriatric schizophrenic patients. Am J Psychia- try 1995;152:197–207.
  • Arnold SE, Gur RE, Shapiro RM, Fisher KR, Moberg PJ, Gib- ney MR, et al. Prospective clinicopathologic studies of schizo- phrenia: accrual and assessment. Am J Psychiatry 1995; 152:731–7.
  • Harvey PD, Silverman JM, Mohs RC, Parella M, White L, Powchik P, et al. Cognitive decline in late-life schizophrenia: a longitudinal study of geriatric chronically hospitalized pa- tients. Biol Psychiatry 1999;45:32–40.
  • Kurtz MM, Moberg PJ, Harper-Mozley L, Hickey T, Arnold SE, Gur RE. The relationship of neuropsychological impair- ment to functional outcome in elderly patients with schizo- phrenia. Int J Geriatr Psychiatry [In press].
  • Mockler D, Riordan J, Sharma T. Memory and intellectual deficits do not decline with age in schizophrenia. Schizophr Res 1997;26:1–7.
  • Lindenmayer JP, Negron AE, Shah S, Lowinger R, Kennedy G, Bark N, et al. Cognitive deficits and psychopathology in elderly schizophrenic patients. Am J Geriatr Psychiatry 1997;5:31–42.
  • Klapow JC, Evans J, Patterson TL, Heaton RK, Koch WL, Jeste DV. Direct assessment of functional status in older pa- tients with schizophrenia. Am J Psychiatry 1997;154:1022–4.
  • Davidson M, Harvey P, Welsh KA, Powchik P, Putnam KM, Mohs RC. Cognitive functioning in late-life schizophrenia: a comparison of elderly schizophrenic patients and patients with Alzheimer’s disease. Am J Psychiatry 1996;153:1274–9.
  • Bruton CJ, Crow TJ, Frith CD, Johnstone EC, Owens DG, Roberts GW. Schizophrenia and the brain: a prospective clinico-neuropathological study. Psychol Med 1990;20:285- 304.
  • Golier JA, Davidson M, Haroutunian V, Powchik P, Puro- hit D, Perl D, et al. Neuropathological study of 101 elderly schizophrenics: preliminary findings [Abstract]. Schizophr Res 1995;15:120.
  • Larson EB, Reifler BV, Featherstone HJ, English DR. De- mentia in elderly outpatients: a prospective study. Ann In- tern Med 1984;100:417–23.
  • Braak H, Braak E. Neuropathological staging of Alzheimer- related changes. Acta Neuropathol (Berl) 1991;82:239–59.
  • Arnold SE, Hyman BT, Flory J, Damasio AR, Van Hoesen GW. The topographical and neuroanatomical distribution of neurofibrillary tangles and neuritic plaques in the cerebral cortex of patients with Alzheimer’s disease. Cereb Cortex 1991;1:103–16.
  • Arnold SE. Cellular and molecular pathology of the frontal lobe dementias. In: Trojanowski JQ, Clark CM, eds. Neuro- degenerative dementia: clinical and pathological mecha- nisms. New York: McGraw-Hill, 2000:291–300.
  • Arnold SE, Franz BR, Trojanowski JQ. Elderly patients with schizophrenia exhibit infrequent neurodegenerative lesions. Neurobiol Aging 1994;15:299–303.
  • Arnold SE, Trojanowski JQ, Gur RE, Blackwell P, Han LY, Choi C. Absence of neurodegeneration and neural injury in the cerebral cortex in a sample of elderly patients with schizophrenia. Arch Gen Psychiatry 1998;55:225–32.
  • Casanova MF, Carosella NW, Gold JM, Kleinman JE, Wein- berger DR, Powers RE. A topographical study of senile plaques and neurofibrillary tangles in the hippocampi of pa- tients with Alzheimer’s disease and cognitively impaired pa- tients with schizophrenia. Psychiatry Res 1993;49:41–62.
  • Purohit DP, Perl DP, Haroutunian V, Powchik P, Davidson M, Davis KL. Alzheimer disease and related neurodegenerative diseases in elderly patients with schizophrenia: a postmor- tem neuropathologic study of 100 cases. Arch Gen Psychia- try 1998;55:205–11.
  • Arnold SE, Trojanowski JQ, Parchi P. Protease resistant prion proteins are not present in sporadic “poor outcome” schizophrenia. J Neurol Neurosurg Psychiatry 1999;66:90–2.
  • Haroutunian V, Davidson M, Kanof PD, Perl DP, Powchik P, Losonczy M, et al. Cortical cholinergic markers in schizo- phrenia. Schizophr Res 1994;12:137–44.
  • Norton WT, Aquino DA, Hozumi I, Chiu F-C, Brosnan CF. Quantitative aspects of reactive gliosis: a review. Neurochem Res 1992;17:877–85.
  • Stevens JR. Neuropathology of schizophrenia. Arch Gen Psy- chiatry 1982;39:1131–9.
  • Stevens CD, Altshuler LL, Bogerts B, Falkai P. Quantitative study of gliosis in schizophrenia and Huntington’s chorea. Biol Psychiatry 1988;24:697–700.
  • Crow TJ, Ball J, Bloom SR, Brown R, Bruton CJ, Colter N, et al. Schizophrenia as an anomaly of development of cerebral asymmetry. A postmortem study and a proposal concerning the genetic basis of the disease. Arch Gen Psychiatry 1989; 46:1145–50.
  • Roberts GW, Colter N, Lofthouse R, Johnstone EC, Crow TJ. Is there gliosis in schizophrenia? Investigation of the tem- poral lobe. Biol Psychiatry 1987;22:1459–68.
  • Roberts GW, Colter N, Lofthouse R, Bogerts B, Zech M, Crow TJ. Gliosis in schizophrenia: a survey. Biol Psychiatry 1986; 21:1043–50.
  • Falke E, Han LY, Arnold SE. Absence of neurodegeneration in thalamus and caudate in elderly patients with schizophre- nia. Psychiatry Res 2000;93:63–110.
  • Kempermann G, Kuhn HG, Gage FH. Experience-induced neurogenesis in the senescent dentate gyrus. J Neurosci 1998;18:3206–12.
  • Kempermann G, Gage FH. Experience-dependent regulation of adult hippocampal neurogenesis: effects of long-term stim- ulation and stimulus withdrawal. Hippocampus 1999;9:321–2.
  • Gabriel A. Disorientation in chronic psychiatric patients. Can J Psychiatry 1997;42:864–8.
  • Michael A, Mathai PJ, Chaturvedi SK, Gopinath PS. Stabil- ity of negative symptoms of schizophrenia [Letter; Com- ment]. Br J Psychiatry 1992;160:281.
  • Mathai PJ, Gopinath PS. Deficits of chronic schizophrenia in relation to long-term hospitalization. Br J Psychiatry 1986; 148:509–16.
  • Cannon TD, Kaprio J, Lonnqvist J, Huttunen M, Kosken- vuo M. The genetic epidemiology of schizophrenia in a Fin- nish twin cohort. A population-based modeling study. Arch Gen Psychiatry 1998;55:67–74.
  • McGuffin P, Anderson P, Owen M, Farmer A. The strength of the genetic effect. Is there room for an environmental influ- ence in the aetiology of schizophrenia? Br J Psychiatry 1994;164:593–9.
  • Susser E, Neugebauer R, Hoek HW, Brown AS, Lin S, Labov- itz D, et al. Schizophrenia after prenatal famine. Further evi- dence. Arch Gen Psychiatry 1996;53:25–31.
  • Mednick SA, Machon RA, Huttunen MO, Bonnett D. Adult schizophrenia following prenatal exposure to an influenza epidemic. Arch Gen Psychiatry 1988;45:189–92.
  • Hollister JM, Laing P, Mednick SA. Rhesus incompatibility as a risk factor for schizophrenia in male adults. Arch Gen Psychiatry 1996;53:19–24.
  • Cannon TD, Rosso IM, Hollister JM, Bearden CE, Sanchez LE, Hadley T. A prospective cohort study of genetic and peri- natal influences in the etiology of schizophrenia. Schizophr Bull 2000;26:351–66.
  • O’Callaghan E, Larkin C, Kinsella A, Waddington JL. Famil- ial, obstetric, and other clinical correlates of minor physical anomalies in schizophrenia. Am J Psychiatry 1991;148:479–83.
  • McNeil TF, Cantor-Graae E, Nordstrom LG, Rosenlund T. Head circumference in ‘preschizophrenics’ and control neo- nates. Br J Psychiatry 1993;162:517–23.
  • Walker E. Developmentally moderated expressions of the neuropathology underlying schizophrenia. Schizophr Bull 1994;20:453–80.
  • Jones P, Rodgers B, Murray R, Marmot M. Child develop- ment risk factors for adult onset schizophrenia in the British 1946 birth cohort. Lancet 1994;344:1398–402.
  • Nowakowski RS, Rakic P. The site of origin and route and rate of migration of neurons to the hippocampal region in the rhesus monkey. J Comp Neurol 1981;196:129–54.
  • Arnold SE, Trojanowski JQ. Human fetal hippocampal devel- opment, I: Cytoarchitecture, myeloarchitecture and neuronal morphologic features. J Comp Neurol 1996;367:274–92.
  • Arnold SE, Trojanowski JQ. Human fetal hippocampal devel- opment, II: The neuronal cytoskeleton. J Comp Neurol 1996; 367:293–307.
  • Eriksson PS, Perfilieva E, Bjork-Eriksson T, Alborn AM, Nordborg C, Peterson DA, et al. Neurogenesis in the adult human hippocampus. Nat Med 1998;4:1313–7.
  • Kovelman JA, Scheibel AB. A neurohistological correlate of schizophrenia. Biol Psychiatry 1984;19:1601–21.
  • Conrad AJ, Abebe T, Austin R, Forsythe S, Scheibel AB. Hip- pocampal pyramidal cell disarray in schizophrenia as a bilat- eral phenomenon. Arch Gen Psychiatry 1991;48:413–7.
  • Jakob H, Beckmann H. Prenatal developmental distur- bances in the limbic allocortex in schizophrenics. J Neural Transm 1986;65:303–26.
  • Jakob H, Beckmann H. Gross and histological criteria for de- velopmental disorders in brains of schizophrenics. J R Soc Med 1989;82:466–9.
  • Jakob H, Beckmann H. Circumscribed malformation and nerve cell alterations in the entorhinal cortex of schizophren- ics. Pathogenetic and clinical aspects. J Neural Transm Gen Sect 1994;98:83–106.
  • Arnold SE, Hyman BT, Van Hoesen GW, Damasio AR. Some cytoarchitectural abnormalities of the entorhinal cortex in schizophrenia. Arch Gen Psychiatry 1991;48:625–32.
  • Falkai P, Schneider-Axmann T, Honer WG. Entorhinal cortex pre-alpha cell clusters in schizophrenia: quantitative evi- dence of a developmental abnormality. Biol Psychiatry 2000; 47:937–43.
  • Longson D, Deakin JF, Benes FM. Increased density of ento- rhinal glutamate-immunoreactive vertical fibers in schizo- phrenia. J Neural Transm 1996;103:503–7.
  • Akil M, Lewis DA. The catecholaminergic innervation of the human entorhinal cortex: alterations in schizophrenia. Soc Neurosci Abstr 1995;21:238.
  • Altshuler LL, Conrad A, Kovelman JA, Scheibel A. Hippo- campal pyramidal cell orientation in schizophrenia. A con- trolled neurohistologic study of the Yakovlev collection. Arch Gen Psychiatry 1987;44:1094–8.
  • Arnold SE, Franz BR, Gur RC, Gur RE, Shapiro RM, Moberg PJ, et al. Smaller neuron size in schizophrenia in hippocampal subfields that mediate cortical-hippocampal interactions. Am J Psychiatry 1995;152:738–48.
  • Benes FM, Sorensen I, Bird ED. Reduced neuronal size in posterior hippocampus of schizophrenic patients. Schizophr Bull 1991;17:597–608.
  • Christison GW, Casanova MF, Weinberger DR, Rawlings R, Kleinman JE. A quantitative investigation of hippocampal pyramidal cell size, shape, and variability of orientation in schizophrenia. Arch Gen Psychiatry 1989;46:1027–32.
  • Zaidel DW, Esiri MM, Harrison PJ. Size, shape, and orienta- tion of neurons in the left and right hippocampus: investiga- tion of normal asymmetries and alterations in schizophrenia. Am J Psychiatry 1997;154:812–8.
  • Akil M, Lewis DA. Cytoarchitecture of the entorhinal cortex in schizophrenia. Am J Psychiatry 1997;154:1010–2.
  • Krimer LS, Herman MM, Saunders RC, Boyd JC, Hyde TM, Carter JM, et al. A qualitative and quantitative analysis of the entorhinal cortex in schizophrenia. Cereb Cortex 1997; 7:732–9.
  • Benes FM, Bird ED. An analysis of the arrangement of neu- rons in the cingulate cortex of schizophrenic patients. Arch Gen Psychiatry 1987;44:608–16.
  • Benes FM, Majocha R, Bird ED, Marotta CA. Increased ver- tical axon numbers in cingulate cortex of schizophrenics. Arch Gen Psychiatry 1987;44:1017–21.
  • Benes FM, McSparren J, Bird ED, SanGiovanni JP, Vincent SL. Deficits in small interneurons in prefrontal and cingu- late cortices of schizophrenic and schizoaffective patients. Arch Gen Psychiatry 1991;48:996–1001.
  • Benes FM, Vincent SL, Alsterberg G, Bird ED, SanGiovanni JP. Increased GABAA receptor binding in superficial layers of cingulate cortex in schizophrenics. J Neurosci 1992;12:924–9.
  • Benes FM, Sorensen I, Vincent SL, Bird ED, Sathi M. In- creased density of glutamate-immunoreactive vertical pro- cesses in superficial laminae in cingulate cortex of schizo- phrenic brain. Cereb Cortex 1992;2:503–12.
  • Benes FM, Todtenkopf MS, Taylor JB. Differential distribu- tion of tyrosine hydroxylase fibers on small and large neu- rons in layer II of anterior cingulate cortex of schizophrenic brain. Synapse 1997;25:80–92.
  • Impagnatiello F, Guidotti AR, Pesold C, Dwivedi Y, Caruncho H, Pisu MG, et al. A decrease of reelin expression as a puta- tive vulnerability factor in schizophrenia. Proc Natl Acad Sci USA 1998;95:15718–23.
  • Barbeau D, Liang JJ, Robitaille Y, Quirion R, Srivastava LK. Decreased expression of the embryonic form of the neural cell adhesion molecule in schizophrenic brains. Proc Natl Acad Sci USA 1995;92:2785–9.
  • Vawter MP, Cannon-Spoor HE, Hemperly JJ, Hyde TM, VanderPutten DM, Kleinman JE, et al. Abnormal expression of cell recognition molecules in schizophrenia. Exp Neurol 1998;149:424–32.
  • Cotter D, Kerwin R, Al-Sarraji S, Brion JP, Chadwich A, Lovestone S, et al. Abnormalities of Wnt signalling in schizo- phrenia—evidence for neurodevelopmental abnormality. Neuroreport 1998;9:1379–83.
  • Miyaoka T, Seno H, Ishino H. Increased expression of Wnt-1 in schizophrenic brains. Schizophr Res 1999;38:1–6.
  • Frith CD, Done DJ. Towards a neuropsychology of schizo- phrenia. Br J Psychiatry 1988;153:437–43.
  • Benes FM. Neurobiological investigations in cingulate cortex of schizophrenic brain. Schizophr Bull 1993;19:537–49.
  • Gray JA, Feldon J, Rawlins JNP, Helmsley DR, Smith AD. The neuropsychology of schizophrenia. Behav Brain Sci 1991; 14:1–84.
  • Stevens JR. Abnormal synaptic reinnervation as the basis of schizophrenia: a hypothesis. Arch Gen Psychiatry 1992;49:238–43.
  • Garey LJ, Ong WY, Patel TS, Kanani M, Davis A, Horn- stein C, et al. Reduction in dendritic spine number on cortical pyramidal neurons in schizophrenia [Abstract]. Soc Neurosci Abstr 1995;21:237.
  • Glantz LA, Lewis DA. Specificity of decreased spine density on layer III pyramidal cells in schizophrenia [Abstract]. Soc Neurosci Abstr 1996;22:1679.
  • Aganova EA, Uranova NA. Morphometric analysis of synap- tic contacts in the anterior limbic cortex in the endogenous psychoses. Neurosci Behav Physiol 1992;22:59–65.
  • Ong WY, Garey LJ. Ultrastructural features of biopsied tem- poropolar cortex (area 38) in a case of schizophrenia. Schizophr Res 1993;10:15–27.
  • Roberts RC, Gaither LA, Peretti F, Conley R, Lapidus B. Stri- atal pathology in schizophrenia: a postmortem ultrastruc- tural study [Abstract]. Soc Neurosci Abstr 1995;21:237.
  • Soustek Z. Ultrastructure of cortical synapses in the brain of schizophrenics. Zentralbl Allgem Pathol 1989;135:25–32.
  • Glantz LA, Lewis DA. Reduction of synaptophysin immuno- reactivity in the prefrontal cortex of subjects with schizo- phrenia. Regional and diagnostic specificity. Arch Gen Psy- chiatry 1997;54:943–52.
  • Gabriel SM, Haroutunian V, Powchik P, Honer WG, David- son M, Davies P, et al. Increased concentrations of presynap- tic proteins in the cingulate cortex of subjects with schizo- phrenia. Arch Gen Psychiatry 1997;54:559–66.
  • Browning MD, Dudek EM, Rapier JL, Leonard S, Freedman R. Significant reductions in synapsin but not synaptophysin specific activity in the brains of some schizophrenics. Biol Psychiatry 1993;34:529–35.
  • Eastwood SL, Burnet PW, Harrison PJ. Altered synaptophy- sin expression as a marker of synaptic pathology in schizo- phrenia. Neuroscience 1995;66:309–19.
  • Honer WG, Falkai P, Young C, Wang T, Xie J, Bonner J, et al. Cingulate cortex synaptic terminal proteins and neural cell adhesion molecule in schizophrenia. Neuroscience 1997; 78:99–110.
  • Lohof AM, Delhaye-Bouchaud N, Mariani J. Synapse elimi- nation in the central nervous system: functional significance and cellular mechanisms. Rev Neurosci 1996;7:85–101.
  • Huttenlocher PR. Synaptic density in human frontal cor- tex—developmental changes and effects of aging. Brain Res 1979;163:195–205.
  • Hoffman RE, McGlashan TH. Synaptic elimination, neurode- velopment, and the mechanism of hallucinated “voices” in schizophrenia. Am J Psychiatry 1997;154:1683–9.
  • McGlashan TH, Hoffman RE. Schizophrenia as a disorder of developmentally reduced synaptic connectivity. Arch Gen Psychiatry 2000;57:637–48.
  • Feinberg I. Schizophrenia: caused by a fault in programmed synaptic elimination during adolescence? J Psychiatr Res 1982;17:319–34.
  • Mortimer JA. Brain reserve and the clinical expression of Alzheimer’s disease. Geriatrics 1997;52(suppl 2): S50-3.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.